Oral contraceptives and breast disease. An epidemiological study

Area of Science:

• Reproductive Health
• Oncology
• Epidemiology

Background:

• Oral contraceptives are widely used by women of reproductive age.
• Understanding their long-term health effects, particularly regarding cancer and benign breast conditions, is crucial.

Purpose of the Study:

• To investigate the association between oral contraceptive use and the risk of breast cancer, ovarian cancer, corpus uteri cancer, and benign breast diseases.
• To examine potential differences in risk based on the type and duration of oral contraceptive use.

Main Methods:

• A case-control study was conducted among women aged 20-44 admitted to Connecticut hospitals.
• Data were collected on oral contraceptive usage patterns and diagnoses of specific cancers and benign breast diseases.

Main Results:

• No significant association was found between oral contraceptive use and breast cancer risk.
• A reduced relative risk of benign breast disease was observed with longer use of sequential oral contraceptives.
• Combination oral contraceptives did not appear to affect the risk of benign breast diseases.
• Insufficient cases precluded conclusions regarding ovarian and corpus uteri cancers.

Conclusions:

• Oral contraceptive use does not appear to increase breast cancer risk.
• Sequential oral contraceptives may offer a protective effect against benign breast disease.
• Further research is needed for gynecological cancers due to limited data.